EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Benzodiazepine Co‐Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose

Adrienne Hughes iD, Hannah Spungen iD, Rachel Culbreth, Kim Aldy, Alex Krotulski iD, Robert G Hendrickson iD, Alexandra Amaducci, Bryan Judge, Christopher Meaden, Diane P Calello, Jennie Buchanan iD, Joseph Carpenter und 7 weitere

Academic Emergency Medicine · 2026-01 · 33 (1)

DOI: 10.1111/acem.70104 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Academic Emergency Medicine, online erschienen am 15.07.2025. Verfasst von Adrienne Hughes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health and Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Benzodiazepines, Emergency Service, Hospital, Opiate Overdose, Analgesics, Opioid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Simultaneous exposure to both benzodiazepines and opioids can lead to synergistic respiratory depression, complicating overdose management. Our objective was to report on the detection of prescription and novel benzodiazepine co‐exposures among patients treated in emergency departments (EDs) with suspected opioid overdoses. We aimed to describe novel benzodiazepine exposures in this population and to compare the clinical severity of co‐exposure to benzodiazepines and opioids versus opioids alone.

Methods

This study utilized data from the Toxicology Investigators Consortium (ToxIC) Fentalog Study, an observational study at 10 ED sites (Sept 2020–Dec 2023). Waste serum samples were analyzed using liquid chromatography quadrupole time‐of‐flight mass spectrometry (LC‐QTOF‐MS) for the presence of over 1200 novel psychoactive substances (NPS), drugs, therapeutics, and metabolites. Analyses included demographics, clinical severity, and outcomes among those with prescription benzodiazepines, novel benzodiazepines, or no benzodiazepines.

Results

Among the patients with opioids present ( n = 1427), 29.0% of patients had detectable benzodiazepines. 20.5% of patients had detectable prescription benzodiazepines, and 8.5% of patients had detectable novel benzodiazepines. The most commonly detected prescription benzodiazepine was alprazolam (39.3%); the most common novel benzodiazepine was bromazolam (46.3% of novel benzodiazepines). The median age of those with novel benzodiazepines was 34, which was younger than those without benzodiazepines (40) and those with prescription benzodiazepines (41; p = 0.001). Patients without benzodiazepines received naloxone more frequently ( p = 0.02), while novel benzodiazepine co‐exposure was associated with higher naloxone nonresponse rates ( p = 0.03). Patients with novel benzodiazepines (compared to the opioid‐only group) had increased odds of requiring mechanical ventilation (aOR: 2.14; 95% CI: 1.07, 4.05) after adjusting for age, gender, race and ethnicity, and the presence of prescription benzodiazepines and/or fentanyl.

Conclusions

Nearly a third of patients with confirmed opioid overdose presenting to the ED also had concomitant benzodiazepine exposures. Those with novel benzodiazepines had significantly higher odds of intubation, suggesting greater severity of overdose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesEmergency Service, HospitalOpiate OverdoseAnalgesics, OpioidDrug OverdoseHumansMaleFemaleAdultMiddle Aged

Stichwörter der Autor:innen

benzodiazepinesnaloxoneopioidsoverdose

Substanzen

BenzodiazepinesAnalgesics, Opioid

Autor:innen und Institutionen

  • Oregon Health and Science University, Portland, Oregon, USA.
  • University of California, Los Angeles, California, USA.
  • American College of Medical Toxicology, Phoenix, Arizona, USA.
  • Baylor University Medical Center, Dallas, Texas, USA.
  • Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania, USA.
  • Lehigh Valley Health Network/USF Morsani College of Medicine, Allentown, Pennsylvania, USA.

ORCID-Profile: Adrienne Hughes, Hannah Spungen, Alex Krotulski, Robert G Hendrickson, Jennie Buchanan, Michael Levine

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Hughes, A., Spungen, H., Culbreth, R., Aldy, K., Krotulski, A., Hendrickson, R. G., Amaducci, A., Judge, B., Meaden, C., Calello, D. P., Buchanan, J., Carpenter, J., Shulman, J., Brent, J., Wax, P., Campleman, S., Levine, M., Schwarz, E., & Manini, A. F. (2026). Benzodiazepine Co‐Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose. Academic Emergency Medicine, 33(1). https://doi.org/10.1111/acem.70104

Vancouver

Hughes A, Spungen H, Culbreth R, Aldy K, Krotulski A, Hendrickson RG, et al. Benzodiazepine Co‐Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose. Academic Emergency Medicine. 2026;33(1). doi:10.1111/acem.70104

BibTeX
@article{Hughes2026,
  author = {Hughes, Adrienne and Spungen, Hannah and Culbreth, Rachel and Aldy, Kim and Krotulski, Alex and Hendrickson, Robert G and Amaducci, Alexandra and Judge, Bryan and Meaden, Christopher and Calello, Diane P and Buchanan, Jennie and Carpenter, Joseph and Shulman, Joshua and Brent, Jeffrey and Wax, Paul and Campleman, Sharan and Levine, Michael and Schwarz, Evan and Manini, Alex F},
  title = {Benzodiazepine Co‐Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose},
  journal = {Academic Emergency Medicine},
  year = {2026},
  volume = {33},
  number = {1},
  doi = {10.1111/acem.70104}
}
Kostenlos starten →